Shortage worries: Past supply issues left many people scrambling
Alongside lifestyle treatment, clinicians may consider options such as sleeve gastrectomy when medically appropriate
While glucagon receptor agonism alone could raise blood glucose levels, this effect is counterbalanced by the simultaneous GLP-1 and GIP receptor activation, which enhance insulin secretion and glucose disposal
At 24 weeks, the mean relative change from baseline in liver fat was a 42.9% reduction in the 1 mg group, a 57.0% reduction at 4 mg, an 81.4% reduction at 8 mg, and an 82.4% reduction at the 12 mg dose
Why people consider GLP-1s: weight loss leads, with clear gender differences Among respondents who currently take, have taken, or would consider taking a GLP-1 (or an alternative), the leading motivation is weight loss: Canada : 58% cite weight loss as a primary reason
Novo Nordisk is conducting a clinical trial to study safety outcomes of infants born to pregnant people exposed to Wegovy and other weight loss medications during pregnancy